Last updated: 2026-09-21 17:50:01. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Absci Corporation (ABSI) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and is listed on NASDAQ. The stock is currently priced at $9.74, with a market capitalization of $1.66B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.24 to $12.06. This page covers its latest market performance, valuation, price trends and company information.
$1.66B | |
$10.06 | |
$31.53 | |
$1.11 | |
$9.65 | |
1.99M | |
4.45M | |
-- | |
$12.06 | |
$2.24 | |
-- | |
-- |
Absci Corporation (ABSI) is currently trading at $9.74 as of 2026-09-21 17:34:23, up 0.88% ($0.08) from the previous close of $9.65
During today's regular trading session, ABSI has traded between $1.11 and $31.53, with a trading volume of 1.99M shares. The current price is near the lower end of today's range.
Over the past seven days, Absci Corporation (ABSI) moved from $8.24 to $9.74, representing a gain of 18.14% ($1.49).
The stock traded between $7.79 and $10.08 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 4.20 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 76.4%
ABSI is currently trading at $9.74, placing it 76.4% of the way from its 52-week low of $2.24 to its 52-week high of $12.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Employees | 140 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Absci Corporation (ABSI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.